- Conditions
- Adnexal Diseases, Carcinoma, Carcinoma, Ovarian Epithelial, +22 more
- Locations
-
- University of Alabama at Birmingham (UAB) Hospital /ID# 274793 Birmingham, Alabama, United States
- Usa Mitchell Cancer Institute /ID# 276022 Mobile, Alabama, United States
- University of California Los Angeles Medical Center /ID# 274566 Los Angeles, California, United States
- Scripps Md Anderson - Prebys Cancer Center /ID# 276891 San Diego, California, United States
Clinical trial condition
Neoadjuvant
Explore clinical trials studying Neoadjuvant. Study availability and eligibility vary by location and protocol.
9 public trials
7 recruiting studies
Neoadjuvant trial results
NCT05738694
- Conditions
- Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +15 more
- Locations
-
- Cancer Hospital Chinese Academy of Medical Sciences Beijing, China
- Peking University First Hospital Beijing, China
- Sun Yat-sen University Cancer Center Guangzhou, China
- Anhui Provincial Hospital Hefei, China
NCT07385001
- Conditions
- Carcinoma, Carcinoma, Squamous Cell, Digestive System Diseases, +14 more
- Locations
-
- Tangdu Hospitial Xi'an, Shannxi, China
NCT05512481
- Conditions
- Acral Melanoma, Apatinib, Camrelizumab, +15 more
- Locations
-
- Beijing Cancer Hospital Beijing, Beijing Municipality, China
NCT06479460
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +7 more
- Locations
-
- Jiangsu Province Hospital Nanjing, Jiangsu, China
NCT06000917
- Conditions
- Breast Cancer, Breast Diseases, Breast Neoplasms, +5 more
- Locations
-
- WuhanHU Wuhan, Hubei, China
- Union Hospital Affiliated to Tongji Medical College, Huazhong University of Science and Technology Wuhan, Hubei, China
NCT04933669
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Gastrointestinal Diseases, +9 more
- Locations
-
- The First Affiliated Hospital, College of Medicine, Zhejiang University Hangzhou, Zhejiang, China
NCT06129812
- Conditions
- Digestive System Diseases, Digestive System Neoplasms, Endocrine Gland Neoplasms, +7 more
- Locations
-
Not specified
Active, Not Recruiting
Pembrolizumab in Combination With Eftilagimod Alpha and Radiotherapy in Neoadjuvant Treatment of Patients With Soft Tissue Sarcoma - EFTISARC-NEO Trial
NCT06128863
- Conditions
- Immunotherapy, Neoadjuvant, Neoplasms, +5 more
- Locations
-
- Maria Sklodowska-Curie National Research Institute of Oncology Warsaw, Poland